No abstract available
MeSH terms
-
Adult
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Clinical Trials as Topic
-
Dermatologic Agents / adverse effects*
-
Female
-
Humans
-
Interleukin-17 / antagonists & inhibitors
-
Interleukin-17 / immunology
-
Latent Tuberculosis / diagnosis
-
Latent Tuberculosis / epidemiology*
-
Latent Tuberculosis / immunology
-
Male
-
Middle Aged
-
Prevalence
-
Psoriasis / diagnosis
-
Psoriasis / drug therapy*
-
Psoriasis / immunology
-
Severity of Illness Index
-
Treatment Outcome
-
Tuberculin Test
Substances
-
Antibodies, Monoclonal, Humanized
-
Dermatologic Agents
-
IL17A protein, human
-
Interleukin-17
-
ixekizumab